Prostate Cancer Clinical Trial
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Summary
The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.
Full Description
Participants will be asked to complete a questionnaire about their health prior to treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.
Eligibility Criteria
Inclusion Criteria:
Pathological diagnosis of an adenocarcinoma of the prostate
18 years of age or older
Prior choice of either standard brachytherapy or MRIGPB as primary treatment
Exclusion Criteria:
Prior primary therapy (surgery or external beam radiation) for prostate cancer
Current hormone ablation therapy
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Boston Massachusetts, 02114, United States More Info
Principal Investigator
Boston Massachusetts, 02115, United States More Info
Principal Investigator
Boston Massachusetts, 02215, United States More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.